Dear Colleagues,
Intrauterine pathologies, such as endometrial polyps, myomas, synechiae, hyperplasia, and endometrial cancer, are one of the most common disorders in the female population, both in reproductive-aged women and postmenopausal ones. Also inflammatory diseases, in particular endometritis, are a very common pathology often difficult to identify that may cause abnormal uterine bleeding and infertility.
Hysteroscopy represents the gold standard management of these diseases. On the one hand, diagnostic hysteroscopy, using small diameter scopes in ambulatory setting, offers the possibility of direct vision and biopsy of vagina and fornices, cervical canal, uterine cavity and tubal ostia; on the other hand, intracavitary surgical procedures may be performed both in office setting (see-and-treat approach) or operating room, depending on the complexity of the procedure.
Despite the recent technical improvements of hysteroscopy, the pathogenesis of several intrauterine diseases, such as polyps, submucosal myomas, uterine anomalies as well as endometrial pre-cancerous lesions, still remains to be clearly determined.
In this scenario, the possibility offered by hysteroscopy-guided targeted endometrial biopsy may enhance the possibility to study these conditions even from the molecular point of view, from the genetic background to the epigenetic modifications that may lead to endometrial/myometrial pathological changes.
In addition, the improved understanding of molecular mechanism behind intrauterine disease may lead to a proper, molecular-based, early diagnosis and target therapy, taking into account also the clear role of hormonal changes. Finally, the combination of intracavitary view offered by hysteroscopy and investigation of expression of some genes pivotal for the correct anatomical development of the reproductive tract, such as the ones from HOX transcription family, could be useful to shed new lights about common uterine malformation, such as uterine septa and subsepta, and even less common ones.
Considering all these elements, the Special Issue “Hysteroscopic approach to intrauterine diseases: from molecular basis to clinical management” aims to publish both original researches as well as comprehensive review about molecular mechanisms involved in the clinical management of intrauterine diseases diagnosed and treated by hysteroscopy as well as the impact of these pathologies on female fertility. In particular, the Special Issue welcomes the possibility to explore the role of the knowledge about molecular processes in the clinical practice for the diagnosis and treatments of these diseases.
You may choose our Joint Special Issue in IJMS.
Salvatore Giovanni Vitale M.D. Ph.D.
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript.
The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs).
Submitted papers should be well formatted and use good English. Authors may use MDPI's
English editing service prior to publication or during author revisions.